Literature DB >> 20677340

ICC density predicts bacterial overgrowth in a rat model of post-infectious IBS.

Sam-Ryong Jee1, Walter Morales, Kimberly Low, Christopher Chang, Amy Zhu, Venkata Pokkunuri, Soumya Chatterjee, Edy Soffer, Jeffrey L Conklin, Mark Pimentel.   

Abstract

AIM: To investigate the interstitial cells of Cajal (ICC) number using a new rat model.
METHODS: Sprague-Dawley rats were assigned to two groups. The first group received gavage with Campylobacter jejuni (C. jejuni) 81-176. The second group was gavaged with placebo. Three months after clearance of Campylobacter from the stool, precise segments of duodenum, jejunum, and ileum were ligated in self-contained loops of bowel that were preserved in anaerobic bags. Deep muscular plexus ICC (DMP-ICC) were quantified by two blinded readers assessing the tissue in a random, coded order. The number of ICC per villus was compared among controls, Campylobacter recovered rats without small intestinal bacterial overgrowth (SIBO), and Campylobacter recovered rats with SIBO.
RESULTS: Three months after recovery, 27% of rats gavaged with C. jejuni had SIBO. The rats with SIBO had a lower number of DMP-ICC than controls in the jejunum and ileum. Additionally there appeared to be a density threshold of 0.12 DMP-ICC/villus that was associated with SIBO. If ileal density of DMP-ICC was < 0.12 ICC/villus, 54% of rats had SIBO compared to 9% among ileal sections with > 0.12 (P < 0.05). If the density of ICC was < 0.12 DMP-ICC/villus in more than one location of the bowel, 88% of these had SIBO compared to 6% in those who did not (P < 0.001).
CONCLUSION: In this post-infectious rat model, the development of SIBO appears to be associated with a reduction in DMP-ICC. Further study of this rat model might help understand the pathophysiology of post-infectious irritable bowel syndrome.

Entities:  

Mesh:

Year:  2010        PMID: 20677340      PMCID: PMC2915428          DOI: 10.3748/wjg.v16.i29.3680

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  39 in total

1.  Persistent intestinal neuromuscular dysfunction after acute nematode infection in mice.

Authors:  G Barbara; B A Vallance; S M Collins
Journal:  Gastroenterology       Date:  1997-10       Impact factor: 22.682

2.  Study of the interstitial cells of Cajal in infantile hypertrophic pyloric stenosis.

Authors:  J M Vanderwinden; H Liu; M H De Laet; J J Vanderhaeghen
Journal:  Gastroenterology       Date:  1996-08       Impact factor: 22.682

3.  Ultrastructure of interstitial cells of Cajal at the colonic submuscular border in patients with ulcerative colitis.

Authors:  J J Rumessen
Journal:  Gastroenterology       Date:  1996-12       Impact factor: 22.682

4.  Development of electrical rhythmicity in the murine gastrointestinal tract is specifically encoded in the tunica muscularis.

Authors:  S M Ward; S C Harney; J R Bayguinov; G J McLaren; K M Sanders
Journal:  J Physiol       Date:  1997-11-15       Impact factor: 5.182

5.  Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients.

Authors:  K R Neal; J Hebden; R Spiller
Journal:  BMJ       Date:  1997-03-15

6.  Increased mast cells in the irritable bowel syndrome.

Authors:  M O'Sullivan; N Clayton; N P Breslin; I Harman; C Bountra; A McLaren; C A O'Morain
Journal:  Neurogastroenterol Motil       Date:  2000-10       Impact factor: 3.598

7.  Psychometric scores and persistence of irritable bowel after infectious diarrhoea.

Authors:  K A Gwee; J C Graham; M W McKendrick; S M Collins; J S Marshall; S J Walters; N W Read
Journal:  Lancet       Date:  1996-01-20       Impact factor: 79.321

8.  Achalasia. A morphologic study of 42 resected specimens.

Authors:  J R Goldblum; R I Whyte; M B Orringer; H D Appelman
Journal:  Am J Surg Pathol       Date:  1994-04       Impact factor: 6.394

9.  c-kit-dependent development of interstitial cells and electrical activity in the murine gastrointestinal tract.

Authors:  S Torihashi; S M Ward; S Nishikawa; K Nishi; S Kobayashi; K M Sanders
Journal:  Cell Tissue Res       Date:  1995-04       Impact factor: 5.249

10.  A new rat model links two contemporary theories in irritable bowel syndrome.

Authors:  Mark Pimentel; Soumya Chatterjee; Christopher Chang; Kimberly Low; Yuli Song; Chengxu Liu; Walter Morales; Lemeesa Ali; Sheila Lezcano; Jeffery Conklin; Sydney Finegold
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

View more
  18 in total

1.  Second-Generation Biomarker Testing for Irritable Bowel Syndrome Using Plasma Anti-CdtB and Anti-Vinculin Levels.

Authors:  Walter Morales; Ali Rezaie; Gillian Barlow; Mark Pimentel
Journal:  Dig Dis Sci       Date:  2019-05-31       Impact factor: 3.199

2.  Antibiotics for the treatment of irritable bowel syndrome.

Authors:  Robert J Basseri; Stacy Weitsman; Gillian M Barlow; Mark Pimentel
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-07

3.  Assessment of Anti-vinculin and Anti-cytolethal Distending Toxin B Antibodies in Subtypes of Irritable Bowel Syndrome.

Authors:  Ali Rezaie; Sung Chul Park; Walter Morales; Emily Marsh; Anthony Lembo; Jae Hak Kim; Stacy Weitsman; Kathleen S Chua; Gillian M Barlow; Mark Pimentel
Journal:  Dig Dis Sci       Date:  2017-04-27       Impact factor: 3.199

4.  Chronic diarrhea in travelers.

Authors:  Bradley A Connor
Journal:  Curr Infect Dis Rep       Date:  2013-06       Impact factor: 3.725

5.  Postinfectious functional gastrointestinal disorders: a focus on epidemiology and research agendas.

Authors:  Adam Deising; Ramiro L Gutierrez; Chad K Porter; Mark S Riddle
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-03

Review 6.  The chronic gastrointestinal consequences associated with campylobacter.

Authors:  Mark S Riddle; Ramiro L Gutierrez; Elena F Verdu; Chad K Porter
Journal:  Curr Gastroenterol Rep       Date:  2012-10

7.  Rome Foundation Working Team Report on Post-Infection Irritable Bowel Syndrome.

Authors:  Giovanni Barbara; Madhusudan Grover; Premysl Bercik; Maura Corsetti; Uday C Ghoshal; Lena Ohman; Mirjana Rajilić-Stojanović
Journal:  Gastroenterology       Date:  2018-11-28       Impact factor: 22.682

Review 8.  Antibiotics for irritable bowel syndrome: rationale and current evidence.

Authors:  Amit H Sachdev; Mark Pimentel
Journal:  Curr Gastroenterol Rep       Date:  2012-10

9.  Role of Cytolethal Distending Toxin in Altered Stool Form and Bowel Phenotypes in a Rat Model of Post-infectious Irritable Bowel Syndrome.

Authors:  Venkata Pokkunuri; Mark Pimentel; Walter Morales; Sam-Ryong Jee; Joel Alpern; Stacy Weitsman; Zachary Marsh; Kimberly Low; Laura Hwang; Reza Khoshini; Gillian M Barlow; Hanlin Wang; Christopher Chang
Journal:  J Neurogastroenterol Motil       Date:  2012-10-09       Impact factor: 4.924

10.  The gut microbiota and irritable bowel syndrome: friend or foe?

Authors:  Uday C Ghoshal; Ratnakar Shukla; Ujjala Ghoshal; Kok-Ann Gwee; Siew C Ng; Eamonn M M Quigley
Journal:  Int J Inflam       Date:  2012-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.